← back to search

Chi Gao

North China University of Science and Technology Affiliated Hospital · CN
🔎 Find collaborators in Genetics · Pathology and Forensic Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, Nutrition, Genetics, and Disease, and Lymphoma Diagnosis and Treatment.
h-index
14
citations
2,565
works
42
NIH funding
primary concept
Medicine
email

Recent publications

Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Clinical Lymphoma Myeloma & Leukemia 2024cited by 3position: middledoi
POSTER: ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Clinical Lymphoma Myeloma & Leukemia 2023cited by 0position: middledoi
A Population-Based Study of Genes Previously Implicated in Breast Cancer
New England Journal of Medicine 2021cited by 849position: middledoi
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score
Journal of Clinical Oncology 2021cited by 94position: firstdoi
Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries
International Journal of Epidemiology 2021cited by 74position: middledoi
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Journal of Clinical Oncology 2021cited by 38position: middledoi
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
The American Journal of Human Genetics 2021cited by 12position: middledoi
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
Journal of Translational Genetics and Genomics 2021cited by 0position: middledoi
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
JNCI Journal of the National Cancer Institute 2020cited by 77position: middledoi
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
JNCI Journal of the National Cancer Institute 2020cited by 73position: middledoi
Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation
Cancer Epidemiology Biomarkers & Prevention 2020cited by 46position: middledoi
Abstract PD3-01: Population-based breast cancer risk estimates for predisposition gene mutations: Results from the CARRIERS study
Cancer Research 2020cited by 0position: middledoi
The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis
International Journal of Epidemiology 2019cited by 66position: middledoi
Two truncating variants in FANCC and breast cancer risk
Scientific Reports 2019cited by 6position: middledoi
Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries
medRxiv 2019cited by 3position: middledoi
Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries
Epidemiology 2019cited by 0position: middledoi
Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer
International Journal of Epidemiology 2016cited by 163position: firstdoi
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study
Scientific Reports 2016cited by 34position: middledoi
Common variants associated with plasma triglycerides and risk for coronary artery disease
Nature Genetics 2013cited by 901position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Kraft · National Cancer Institute5 papers (2016–2021)Christopher A. Haiman · Mayo Clinic in Arizona3 papers (2016–2019)Douglas F. Easton · Pacific Biomarkers (United States)3 papers (2016–2021)Celine M. Vachon · Mayo Clinic2 papers (2020–2021)D. Gareth Evans · Translational Research Institute2 papers (2019–2021)Wei Zheng · Tsinghua University2 papers (2016–2019)Christopher I. Amos · UNM Comprehensive Cancer Center2 papers (2016–2016)Roger L. Milne · Monash Institute of Medical Research2 papers (2019–2021)Joellen M. Schildkraut · Institute of Biomedical Sciences, Academia Sinica1 papers (2016–2016)Brandon L. Pierce · zuChem (United States)1 papers (2016–2016)Richard M. Martin · Cook County Sheriff's Office1 papers (2016–2016)Michael P.A. Davies · University of Liverpool1 papers (2016–2016)Stephen B. Gruber · City Of Hope National Medical Center1 papers (2016–2016)Jian Gong · Tongji University1 papers (2016–2016)Anna H. Wu · University of Southern California1 papers (2019–2019)Sungshim L. Park · University of Hawaiʻi at Mānoa1 papers (2016–2016)Jennifer A. Doherty · University of Utah1 papers (2016–2016)Montserrat García‐Closas · Commonwealth Education Trust1 papers (2021–2021)Mia M. Gaudet · National Cancer Institute1 papers (2021–2021)Hermann Brenner · Stanford University1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Pathology and Forensic Medicine →